LINC00605

Across TCGA pan-cancer cohorts, LINC00605 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC00605 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC00605 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00605 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ACC show a favorable association.

KIRC, ACC, and KICH are the cancer types where LINC00605 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.748	0.506	<.001	105	view →
ACC	OS	Tertile	All	1.000	0.659	.001	77	view →
KICH	DFS	Quartile	II,III,IV	1.000	0.433	.002	55	view →
UVM	DFS	Quartile	All	0.259	0.678	.003	41	view →
READ	OS	Tertile	IV	0.995	0.368	.001	36	view →
LUAD	DFS	Tertile	All	0.558	0.743	<.001	35	view →
LGG	DFS	Tertile	All	0.631	0.769	<.001	32	view →
KIRP	DFS	Quartile	All	0.964	0.808	.002	29	view →
PCPG	DFS	Median	All	0.938	0.558	.001	26	view →
SARC	OS	Median	All	0.660	0.354	.002	20	view →
LAML	DFS	Tertile	All	0.252	0.579	.005	18	view →
COAD	OS	Tertile	II,III,IV	0.746	0.907	.008	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC00605–KIRC (DFS)

Open the KIRC breakdown →